Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
GO BMSN!! LETS ROCK N ROLL!!
BOOOOOOOOOOOOOOOOOMMMMMMMM!!!!!!!!!!!!!
BUY BUY BUY HERE WE GO! ITS COMING!
Come On MMs be nice today! :)
Thats funny all the biotech stocks have the same behavior today...Let the MM games continue!
LMAO! @ the seller on that one ! PPS went right back to normal! Classic!
SHAKE AND BAKE PLAY! HERE WE GO!
PSTI just received orphan drug designation for aplastic anemia! Now what do you think is going to happen to BMSN! Its a no brainer! We Bank! ;)
http://regulatoryaffairs.pharmaceutical-business-review.com/news/pluristem-aplastic-anemia-therapy-wins-fda-orphan-drug-status-220213
Your news headlines are better then TMZ! Luv the entertainment! =D
That would be hilarious! Bwhahaha! Poor little flipper!
Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry's Success
By Marketwire, Marketwire.Com
A sharp increase in drug approvals and mergers and acquisitions combined to create a bull market for the Biotechnology Industry in 2012.
Bloomberg recently reported drug approvals by the U.S. Food and Drug Administration reached a 15 year high in 2012.
The FDA has been approving more applications in the Bio field industry!
http://news.investors.com/newsfeed-marketwire/022213-141440535-sharp-increase-in-fda-drug-approvals-a-major-factor-in-biotech-industrys-success.aspx
Makes you wonder...
On February 1, 2011, Pfizer announced plans to restructure its R&D operations. Overall the company plans to take $1.5 billion out of its drug research programs and use the proceeds to fund a $5 billion dollar stock repurchase program. The reduction in R&D was driven by a decision to reduce the number of disease areas the company will focus on.
Pfizer has announced plans to shift its research and development focus away from heart disease drugs to cancer and biotechnology drugs, which it says are more profitable. The former category includes the company's most profitable product, Lipitor.
$ $Bwhahahaa! BMSN Lookin Good!$$$$
http://www.wikinvest.com/stock/Pfizer_(PFE)
Exactly! No worries here! BMSN is about to go into hyper drive real soon! Fasten your seat belts!
I called the SEC back in Jan. when this was sub penny and asked why would a company delay the 10k and the reasons she gave was: Possible major change in the company and possibly a merger! Which is why I invested 30k and made over 100k in profit! Your right there is something BIG about to happen just wait and see....
Thats AWESOME! PSTI just received orphan drug designation for aplastic anemia! Now what do you think is going to happen to BMSN! Its a no brainer! We Bank! ;)
http://regulatoryaffairs.pharmaceutical-business-review.com/news/pluristem-aplastic-anemia-therapy-wins-fda-orphan-drug-status-220213
CLICK HERE!!!
On February 1, 2011, Pfizer announced plans to restructure its R&D operations. Overall the company plans to take $1.5 billion out of its drug research programs and use the proceeds to fund a $5 billion dollar stock repurchase program. The reduction in R&D was driven by a decision to reduce the number of disease areas the company will focus on.
Pfizer has announced plans to shift its research and development focus away from heart disease drugs to cancer and biotechnology drugs, which it says are more profitable. The former category includes the company's most profitable product, Lipitor.
$ $Bwhahahaa! BMSN Lookin Good!$$$$
http://www.wikinvest.com/stock/Pfizer_(PFE)
Easiest 100k I ever made! ;)
Solid Post! Go BMSN!!
NEWS!!! Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry's Success
By Marketwire, Marketwire.Com
A sharp increase in drug approvals and mergers and acquisitions combined to create a bull market for the Biotechnology Industry in 2012.
Bloomberg recently reported drug approvals by the U.S. Food and Drug Administration reached a 15 year high in 2012.
The FDA has been approving more applications in the Bio field industry!
http://news.investors.com/newsfeed-marketwire/022213-141440535-sharp-increase-in-fda-drug-approvals-a-major-factor-in-biotech-industrys-success.aspx
Totally agree! This is the final week! Don't have time for petty arguments with no relevant supporting data! For now on I just post DD that is all! Anyone with good common sense will make the right judgement call on BMSN! :)
AWESOME! PSTI just received orphan drug designation for aplastic anemia which is the same dease BMSN is treating! Now what do you think is going to happen to BMSN! Its a no brainer! We Bank! BOOM! ;)
http://regulatoryaffairs.pharmaceutical-business-review.com/news/pluristem-aplastic-anemia-therapy-wins-fda-orphan-drug-status-220213
BUYOUT
On February 1, 2011, Pfizer announced plans to restructure its R&D operations. Overall the company plans to take $1.5 billion out of its drug research programs and use the proceeds to fund a $5 billion dollar stock repurchase program. The reduction in R&D was driven by a decision to reduce the number of disease areas the company will focus on.
Pfizer has announced plans to shift its research and development focus away from heart disease drugs to cancer and biotechnology drugs, which it says are more profitable. The former category includes the company's most profitable product, Lipitor.
$$$Bwhahahaa! BMSN Lookin Good!$$$$
http://www.wikinvest.com/stock/Pfizer_(PFE)
NEWS- Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry's Success
By Marketwire, Marketwire.Com
A sharp increase in drug approvals and mergers and acquisitions combined to create a bull market for the Biotechnology Industry in 2012.
Bloomberg recently reported drug approvals by the U.S. Food and Drug Administration reached a 15 year high in 2012.
The FDA has been approving more applications in the Bio field industry!
http://news.investors.com/newsfeed-marketwire/022213-141440535-sharp-increase-in-fda-drug-approvals-a-major-factor-in-biotech-industrys-success.aspx
IF YOU WANT TO CHANGE YOUR LIFE THIS COULD BE THE LAST WEEK TO DO SO! IF YOU ARE ON THE SIDELINE WATCHING YOU HAD MORE THAN ENOUGH TIME TO JUMP IN! GO BMSN!!
AWESOME! PSTI just received orphan drug designation for aplastic anemia which is the same dease BMSN is treating! Now what do you think is going to happen to BMSN! Its a no brainer! We Bank! ;)
http://regulatoryaffairs.pharmaceutical-business-review.com/news/pluristem-aplastic-anemia-therapy-wins-fda-orphan-drug-status-220213
NEWS!!! Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry's Success
By Marketwire, Marketwire.Com
A sharp increase in drug approvals and mergers and acquisitions combined to create a bull market for the Biotechnology Industry in 2012.
Bloomberg recently reported drug approvals by the U.S. Food and Drug Administration reached a 15 year high in 2012.
The FDA has been approving more applications in the Bio field industry!
http://news.investors.com/newsfeed-marketwire/022213-141440535-sharp-increase-in-fda-drug-approvals-a-major-factor-in-biotech-industrys-success.aspx
BUYOUT CLUES!!
On February 1, 2011, Pfizer announced plans to restructure its R&D operations. Overall the company plans to take $1.5 billion out of its drug research
programs and use the proceeds to fund a $5 billion dollar stock repurchase program. The reduction in R&D was driven by a decision to reduce the number of disease areas the company will focus on.
Pfizer has announced plans to shift its research and development focus away from heart disease drugs to cancer and biotechnology drugs, which it says are more profitable. The former category includes the company's most profitable product, Lipitor.
$ $Bwhahahaa! BMSN Lookin Good!$$$$
http://www.wikinvest.com/stock/Pfizer_(PFE)
BUYOUT VERY POSSIBLE!! CLUES!!!
On February 1, 2011, Pfizer announced plans to restructure its R&D operations. Overall the company plans to take $1.5 billion out of its drug research
programs and use the proceeds to fund a $5 billion dollar stock repurchase program. The reduction in R&D was driven by a decision to reduce the number
of disease areas the company will focus on.
Pfizer has announced plans to shift its research and development focus away from heart disease drugs to cancer and biotechnology drugs, which it says
are more profitable. The former category includes the company's most profitable product, Lipitor.
$ $Bwhahahaa! BMSN Lookin Good!$$$$
http://www.wikinvest.com/stock/Pfizer_(PFE)
Thats AWESOME! PSTI just received orphan drug designation for aplastic anemia! Now what do you think is going to happen to BMSN! Its a no brainer! We Bank! ;)
http://regulatoryaffairs.pharmaceutical-business-review.com/news/pluristem-aplastic-anemia-therapy-wins-fda-orphan-drug-status-220213
Rotfl!!! =D Bwahahahahhaa!!!!!!
And its very clear that your the investment consultant angel sent from Narnia or an investor trying to get a god entry point on Monday from panic selling! Bwhahaha! We all know what kind of "angel" you are :)
From your own words
"Bottom line this is being pumped so somebody can dump shares. Then, there is always an array of PR's to follow the promo/pumps. Its text book penny stock non-sense, how people do not see it by now amazes me."
Thats funny cause I see an array of so called "promoters" with no compensation from that laughable website and yet only 2 PRs by BMSN was issued this year! Bwahahaha! =D Your philosophy needs fine tuning! But then again maybe your right after all! This proves BMSN is not a pump and dump! Thank you for your time and awesome DD my kind sir! :)
Exactly just Promos riding the wave! Remember when FB went public there was plenty of PROMOTERS on it! FB didn't pay them! Nor was FB a pump and dump company! We can clearly see who is the NEWBIE investor around here! Enough with the promo "defense". I'm gagging in disgust!
Disclaimer
All information listed within StockPromoters.com was prepared by StockPromoters.com (SP) for the companies discussed within, based upon information supplied by the listed company or from other public information sources believed to be reliable like SEC Filings, Research Reports, Press Releases, News Releases, The Company’s web site or other sources of publicly available information and posted on StockPromoters.com.
Never invest in any stock featured, distributed, posted and/or edited by SP, on SP Web Sites, Emails / Newsletters, Hyperlinks, Social Media posts or Social Media profiles or Social Media networks including Facebook Status / Posts / Updates, Twitter Tweets / Posts / Updates or any other Social Media based source, Blog Postings, YouTube or other Video Content, Corporate Profiles, Research Reports, Analyst Reports, PowerPoint Presentations, Corporate Videos, CEO Video Interviews, Press Releases, Banners, Google / Yahoo/ Bing or other Search Engine Advertising or Listings, Images, and/or Web-Based Discussion Board Postings or any other Electronic Content (Collectively referred to hereafter as “Electronic SP Content “) unless you can afford to lose your entire investment.
The information referred to as Electronic SP Content is not guaranteed by SP to be accurate and should not be considered to be all-inclusive. The companies profiled, promoters listed or other Electronic SP Content have not necessarily approved the statements made herein, either indirectly through information in The Public Company’s SEC Filings, Research Reports, Press Releases, News Releases, The Public Company’s web site, emails sent to subscribers or directly by approving and signing off on Company Profiles or other Electronic SP Content created by SP, which may have also have been taken from SEC Filings, Research Reports, Press Releases, News Releases, The Public Company’s web site or other public information about the company and believed to be reliable.
Interesting why won't they accept full responsibility then! Hmmm! This is a baseless agruement with proof like this! This information on these sites is equivalent to mediatakeout and worldstarhiphop! ROtFl! =D
Restructuring
On February 1, 2011, Pfizer announced plans to restructure its R&D operations. Overall the company plans to take $1.5 billion out of its drug research programs and use the proceeds to fund a $5 billion dollar stock repurchase program. The reduction in R&D was driven by a decision to reduce the number of disease areas the company will focus on.
Pfizer has announced plans to shift its research and development focus away from heart disease drugs to cancer and biotechnology drugs, which it says are more profitable. The former category includes the company's most profitable product, Lipitor.
$$$Bwhahahaa! BMSN Lookin Good!$$$$
http://www.wikinvest.com/stock/Pfizer_(PFE)
NEWS!!! Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry's Success
By Marketwire, Marketwire.Com
A sharp increase in drug approvals and mergers and acquisitions combined to create a bull market for the Biotechnology Industry in 2012.
Bloomberg recently reported drug approvals by the U.S. Food and Drug Administration reached a 15 year high in 2012.
The FDA has been approving more applications in the Bio field industry!
http://news.investors.com/newsfeed-marketwire/022213-141440535-sharp-increase-in-fda-drug-approvals-a-major-factor-in-biotech-industrys-success.aspx
No worries here! My 7.5 Mil shares looking good @.0045 :) This will reach .02+ for sure next week! The pressure is on and March 5 gets closer and closer!
I agree these next two weeks BMSN is going to kick A$$!!
NEWS!!! Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry's Success
By Marketwire, Marketwire.Com
A sharp increase in drug approvals and mergers and acquisitions combined to create a bull market for the Biotechnology Industry in 2012.
Bloomberg recently reported drug approvals by the U.S. Food and Drug Administration reached a 15 year high in 2012.
The FDA has been approving more applications in the Bio field industry!
http://news.investors.com/newsfeed-marketwire/022213-141440535-sharp-increase-in-fda-drug-approvals-a-major-factor-in-biotech-industrys-success.aspx
$$$$IMO COMING$$$$